ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

Cancer Centers Program To Implement Most Changes Sought By review Group

December 13, 1996

NCAB Okays Concepts For ICI Contract Support, Databases

October 11, 1991

The Walgreens Connection: ACS Calls On Drug Stores To Stop Tobacco Sales

April 18, 2014